“Fortunately, long-term survivors are a reality,” says Raquel Ciérvide, MD, PhD, radiation oncologist at HM Sanchinarro University Hospital in Madrid. Discover how modern radiotherapy adapts to the needs of recurring care—preserving both precision and patients’ everyday lives.

When Raquel Ciérvide began her work at HM Sanchinarro University Hospital in the north of Madrid about 15 years ago, each brain metastasis had to be treated individually. Today, with advanced planning and delivery tools, clinicians can treat all lesions in a single session—without compromising precision. For clinicians like Dr. Ciérvide, it means more time to focus on decision-making and individualized patient care.

3_img_doctor.jpg

“This shift not only eases the physical and emotional burden on patients but also improves efficiency for medical teams, reducing time demands on doctors, technicians, and treatment resources.”

Raquel Ciérvide, MD, PhD, Radiation Oncologist, HM Sanchinarro University Hospital, Madrid

As cancer care advances, more patients are living longer—and returning for additional rounds of treatment. For radiation oncologists, this creates a new frontier of challenges: how to safely re-treat previously irradiated areas, how to protect healthy tissue already exposed to radiation, and how to maintain precision when treatment plans span months or even years.

Re-irradiating tissue that has already received high doses of radiation poses significant risks. Damage to healthy brain structures, an increased chance of radionecrosis, and the complexity of accounting for older dose distributions make each decision uniquely challenging.

Modern planning tools help teams navigate these questions by reconstructing dose histories and modeling treatment limits. But Ciérvide emphasizes that no decision is made in isolation. Multidisciplinary tumor boards—including radiation oncologists, medical oncologists, physicists, neuroradiologists, neurosurgeons and other specialists—are essential to mapping out safe and effective care.

With technology designed for the long run, radiotherapy today is not just about targeting tumors—it’s about empowering patients to reclaim their everyday lives.

4_img_doctor.jpg

“I believe that any tool allowing us to focus more on thoughtful clinical decision-making helps not only in our day-to-day work but also benefits patients in tangible ways—by reducing treatment times, enabling them to return to work, and ultimately improving their quality of life. Knowing that they can live well is the most rewarding part.”

The statements made by the healthcare professional during this interview represent their personal opinion and experiences. These statements may not be supported by scientific evidence or peer-review research. For verified information about the device, please refer to the manufacturer’s official documentation or consult clinical guidances.

0_teaser_creator.jpg
Issue 01 | creator | #Radiosurgery

Coding for care: how software is making a difference for patients

One might think it’s challenging enough to develop software that enables the highly precise irradiation of multiple brain metastases in a single session. But as many patients undergo multiple rounds of irradiation, the workflow becomes even more complex. We joined Brainlab R&D Director Cornelis Kamerling and his team tackling these new challenges.
Read article
0_teaser_visionary.jpg
Issue 01 | visionary | #Radiosurgery

The Novalis Certified Program:
“We are the guardians of radiosurgery”

When delivering high-dose radiation to the brain, utmost precision is critical - otherwise, healthy areas may suffer lasting damage. The Novalis Certified program helps hospitals uphold the highest standards of safety and quality. We spoke with Dr. Naren Ramakrishna, a member of the Novalis Expert Group.
Read article
0_teaser_patient.jpg
Issue 01 | patient | #Radiosurgery

“I still need my brain”: Peter Miesbeck’s journey of hope and humor

The diagnosis was devastating: black skin cancer, metastases in the liver, ribs and soft tissue. Five years later - and after undergoing radiotherapy for over 20 brain metastases - Peter Miesbeck recently curated a major Titanic exhibition. A story about the will to live, courage and modern medicine.
Read article